SEC Tracker
Get the app

Sionna Therapeutics SION

Cloonan Michael (Director) plans to sell 99,800 SION shares, about $3.2M

Form
144
Filed
Importance
Routine
  1. Approximate sale date: Oct 21, 2025
  2. Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
  3. Shares acquired by: Exercise of Stock Options
  4. 10b5-1 plan adopted: May 21, 2025

All of Cloonan Michael's insider filings, holdings and planned sales

Form 4s that likely executed this notice (SEC Tracker's match by person, company, dates and shares):

  • Sold 13,324 shares at $34.44 on Oct 21, 2025 · Form 4
  • Sold 30,049 shares at $35.63 on Oct 21, 2025 · Form 4
  • Sold 22,895 shares at $36.6 on Oct 21, 2025 · Form 4
  • Sold 33,532 shares at $37.31 on Oct 21, 2025 · Form 4

Written from the Form 144 on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Sionna Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Emergent BioSolutions EBS public float $343M, Jun 30, 2025
  2. Northwest Biotherapeutics NWBO public float $340M, Jun 30, 2025
  3. Amarin AMRN public float $335M, Jun 30, 2025
  4. Rigel Pharmaceuticals RIGL public float $332M, Jun 30, 2025
  5. Usana Health Sciences USNA public float $328M, Jun 27, 2025